160 related articles for article (PubMed ID: 32304991)
1. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals.
Wang ZM; Xia SW; Zhang T; Wang ZY; Yang X; Kai J; Cheng XD; Shao JJ; Tan SZ; Chen AP; Wang SJ; Zhang F; Zhang ZL; Zheng SZ
Int Immunopharmacol; 2020 Jul; 84():106470. PubMed ID: 32304991
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells.
Wang Z; Yang X; Kai J; Wang F; Wang Z; Shao J; Tan S; Chen A; Zhang F; Wang S; Zhang Z; Zheng S
Life Sci; 2020 Aug; 255():117818. PubMed ID: 32445757
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal.
Xia S; Wang Z; Chen L; Zhou Y; Li Y; Wang S; Chen A; Xu X; Shao J; Zhang Z; Tan S; Zhang F; Zheng S
Biochem Pharmacol; 2021 Oct; 192():114730. PubMed ID: 34400125
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
7. Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
Zhang Z; Zhao S; Yao Z; Wang L; Shao J; Chen A; Zhang F; Zheng S
Redox Biol; 2017 Apr; 11():322-334. PubMed ID: 28038427
[TBL] [Abstract][Full Text] [Related]
8. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
9. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
10. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
Li M; Zhou Y; Zhu H; Xu LM; Ping J
J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
[TBL] [Abstract][Full Text] [Related]
11. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
[TBL] [Abstract][Full Text] [Related]
12. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
13. Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice.
Yi HS; Lee YS; Byun JS; Seo W; Jeong JM; Park O; Duester G; Haseba T; Kim SC; Park KG; Gao B; Jeong WI
Hepatology; 2014 Sep; 60(3):1044-53. PubMed ID: 24668648
[TBL] [Abstract][Full Text] [Related]
14. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.
Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S
Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435
[TBL] [Abstract][Full Text] [Related]
15. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.
Chen M; Liu J; Yang W; Ling W
Autophagy; 2017; 13(11):1813-1827. PubMed ID: 29160747
[TBL] [Abstract][Full Text] [Related]
17. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis.
Dong Z; Li S; Si L; Ma R; Bao L; Bo A
Eur J Clin Invest; 2020 Jun; 50(6):e13243. PubMed ID: 32306379
[TBL] [Abstract][Full Text] [Related]
18. Albumin inhibits the nuclear translocation of Smad3 via interleukin-1beta signaling in hepatic stellate cells.
Park JH; Kim J; Choi SY; Lee B; Lee JE; Park H; Moon JW; Park SH; Lee JM; Lee HS; Oh J
Sci Rep; 2021 Feb; 11(1):3196. PubMed ID: 33542418
[TBL] [Abstract][Full Text] [Related]
19. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
[TBL] [Abstract][Full Text] [Related]
20. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]